Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022					27,141,000	119,747,000
Stockholders' Equity, beginning balance at Jan. 31, 2022	$ 790,378				$ 0	$ 0	$ 1,320,479	$ (562,204)	$ 7,839	$ 24,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					66,162,000	(66,162,000)
Issuance of common stock related to vested exercised stock options (in shares)						2,940,000
Issuance of common stock related to vested exercised stock options	24,846						24,846
Issuance of common stock under employee stock purchase plan (in shares)					437,000
Issuance of common stock under employee stock purchase plan	14,378						14,378
Repurchases, net of early exercised stock options (in shares)						(36,000)
Issuance of common stock related to RSUs vested (in shares)					915,000
Vesting of early exercised stock options	4,706						4,706
Stock-based compensation expense	122,567						114,811			7,756
Change in noncontrolling interest ownership	61,726						18,153			43,573
Deconsolidation of Arch, formerly Meltano	(11,342)									(11,342)
Other comprehensive income (loss)	(10,966)								(8,666)	(2,300)
Net loss	(181,792)							(173,407)		(8,385)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Stockholders' Equity, ending balance at Jan. 31, 2023	814,501				$ 0	$ 0	1,497,373	(735,611)	(827)	53,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					16,995,000	(16,995,000)
Issuance of common stock related to vested exercised stock options (in shares)						3,406,000
Issuance of common stock related to vested exercised stock options	32,448						32,448
Issuance of common stock under employee stock purchase plan (in shares)					417,000
Issuance of common stock under employee stock purchase plan	12,933						12,933
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested (in shares)					2,372,000
Charitable donation of common stock (in shares)			231,408	231,000
Charitable donation of common stock	10,700		$ 10,700				10,700
Vesting of early exercised stock options	1,234						1,234
Stock-based compensation expense	163,049						164,515			(1,466)
Change in noncontrolling interest ownership							(542)			542
Other comprehensive income (loss)	1,063								3,225	(2,162)
Net loss	(429,536)							(425,677)		(3,859)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2024					114,670,000	42,887,000
Stockholders' Equity, ending balance at Jan. 31, 2024	$ 606,392	[1]			$ 0	$ 0	1,718,661	(1,161,288)	2,398	46,621
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					25,933,000	(25,933,000)
Issuance of common stock in connection with business combination, net (in shares)						27,000
Issuance of common stock related to vested exercised stock options (in shares)	2,488,000					2,488,000
Issuance of common stock related to vested exercised stock options	$ 23,973						23,973
Issuance of common stock under employee stock purchase plan (in shares)					420,000
Issuance of common stock under employee stock purchase plan	13,556						13,556
Issuance of common stock related to RSUs vested (in shares)					3,200,000
Charitable donation of common stock (in shares)			221,195	221,000
Charitable donation of common stock	11,827		$ 11,800				11,827
Vesting of early exercised stock options	341						341
Stock-based compensation expense	185,899						184,086			1,813
Change in noncontrolling interest ownership							(413)			413
Other comprehensive income (loss)	(11,563)								(10,906)	(657)
Net loss	(9,119)							(6,326)		(2,793)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2025					144,444,000	19,469,000
Stockholders' Equity, ending balance at Jan. 31, 2025	$ 821,306	[1]			$ 0	$ 0	$ 1,952,031	$ (1,167,614)	$ (8,508)	$ 45,397

[1] (1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.